12 Health Care Stocks Moving In Friday's After-Market Session
12 Health Care Stocks Moving In Friday's After-Market Session
12 個醫療保健股在週五的售後市場會議中移動
Gainers
漲幅
- Invacare (NYSE:IVC) stock rose 14.3% to $0.48 during Friday's after-market session. The market value of their outstanding shares is at $18.1 million.
- Benitec Biopharma (NASDAQ:BNTC) stock increased by 11.7% to $0.19. The market value of their outstanding shares is at $5.3 million.
- AlerisLife (NASDAQ:ALR) stock moved upwards by 9.09% to $0.6. The company's market cap stands at $19.5 million.
- Renalytix (NASDAQ:RNLX) shares rose 8.55% to $2.03. The company's market cap stands at $76.0 million.
- electroCore (NASDAQ:ECOR) shares increased by 8.52% to $0.28. The market value of their outstanding shares is at $19.8 million.
- Statera BioPharma (NASDAQ:STAB) stock increased by 8.37% to $0.09. The company's market cap stands at $4.8 million.
- 入侵 紐約證交所代碼:IVC) 股票在周五的售後市場交易時段上漲 14.3%，至 0.48 美元。他們的流通股市值為 181 百萬美元。
- 貝尼特生物製藥 納斯達克:英國海外貿易中心) 股票上漲 11.7%，至 0.19 美元。其流通股的市值為 530 萬美元。
- 警示生活 （納斯達克：ALR）股票向上移動 9.09%，至 0.6 美元。該公司的市值為 19.5 萬美元。
- 運動售票網 納斯達克：RNLX）股價上漲 8.55%，至 2.03 美元。該公司的市值為 76.0 萬美元。
- 电芯 （納斯達克：經濟）股份增加了 8.52%，至 0.28 美元。其流通股的市值為 19.8 萬美元。
- 斯泰拉生物製藥 （納斯達克：刺）股票增加了 8.37%，至 0.09 美元。該公司的市值為 4.8 萬美元。
Losers
失敗者
- Salarius Pharmaceuticals (NASDAQ:SLRX) shares declined by 13.7% to $1.32 during Friday's after-market session. The company's market cap stands at $3.0 million.
- GreenLight Biosciences (NASDAQ:GRNA) stock declined by 10.17% to $1.06. The company's market cap stands at $160.6 million.
- Intelligent Bio Solutions (NASDAQ:INBS) stock decreased by 8.91% to $0.18. The market value of their outstanding shares is at $3.3 million.
- Baudax Bio (NASDAQ:BXRX) stock declined by 8.5% to $2.91. Trading volume for this security closed at 518.1K, accounting for 46.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $1.6 million.
- Finch Therapeutics Group (NASDAQ:FNCH) shares decreased by 8.32% to $0.44. The market value of their outstanding shares is at $21.0 million.
- Adaptimmune Therapeutics (NASDAQ:ADAP) stock declined by 7.54% to $1.35. The company's market cap stands at $221.1 million. See Also:
- 萨拉利斯制药 （納斯達克：SLRX）股票在周五的售後市場交易時段下跌 13.7%，至 1.32 美元。該公司的市值為 300 萬美元。
- 綠光生物科學 納斯達克：格林納斯）股票下跌 10.17%，至 $1.06。該公司的市值為 1660 萬美元。
- 智能生物方案 (納斯達克:印度) 股票下跌 8.91% 至 0.18 美元。其流通股的市值為 330 萬美元。
- 博達克斯生物 納斯達克：BXRX）股票下跌 8.5%，至 2.91 美元。該證券的交易量在 518.1K 收盤，佔過去 100 天內平均全日交易量的 46.0％。其流通股的市值為 160 萬美元。
- 芬奇治療集團 (納斯達克:FNCH) 股份下跌 8.32% 至 0.44 美元。其流通股的市值為 21.0 百萬美元。
- 適應性芒治療 納斯達克：ADAP）股票下跌 7.54%，至 1.35 美元。該公司的市值為 2.22 億美元。 另請參閱：
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由 Beninga 的自動化內容引擎生成，並由編輯審查。
